Sign inJoin waitlistJoin the waitlist

Tongalp Tezel

Fellowship Director · New York Presbyterian Hospital

Credentials: · · · ·

History

New York Presbyterian Hospital Fellowship
Present
New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present

Washington University School of Medicine
2002–2003
Washington University School of Medicine
1998–2002
SSM St Mary's Hospital-St Louis
1998–1999
Numune Hospital (Ankara
1995–1998
Turkey at Hacettepe University, School
1980–1984

Research

Metastatic disease from uveal melanoma: treatment options and future prospects
Review · British Journal of Ophthalmology · 2017 · 325 citations
Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration?
Ophthalmology · 2008 · Last of 3 authors · 177 citations
Age-related changes in human RPE cell density and apoptosis proportion in situ
Investigative Ophthalmology & Visual Science · 2002 · Last of 3 authors · 168 citations

HK
Henry Kaplan
33 papers
LP
Luciano Del Priore
30 papers
AH
Ahmet Hondur
7 papers · 4 as a resident
AB
Adam Berger
5 papers
RK
Rabia Karani
5 papers · 2 as a resident
Vlad Diaconita
5 papers
SS
Shlomit Schaal
4 papers
Stanley Chang
4 papers
Doru Gucer
3 papers · 2 as a resident
George Cioffi
3 papers
HZ
Henry Zhou
3 papers
Jason Horowitz
3 papers

Grants

Proteomic Analysis of Age-Related Macular Degeneration
National Eye Institute · K08
Contact PI · $445.5K · University of Louisville
2005–2008

Clinical trials

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
2026–2029
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Site PI · Recruiting · Phase 3
4D Molecular Therapeutics
2025–2029